Congratulations to Emily Houston, PhD Candidate in CTS, on receiving notice of funding from Neurocrine Biosciences! Emily will serve as PI of the $128,000 grant for her project, Evaluating a Telemedicine Neurological Consult Program for Drug-Induced Movement Disorders (DIMD) using the RE-AIM Framework. James Boyd, MD from Neurology is serving as Emily’s research mentor and Amanda Kennedy, Pharm. D. is her CTS academic advisor. Congratulations Emily. Well deserved!
Tuesday, June 29, 2021
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.